DD
T3DuPont de Nemours, Inc.
Loading chart…
OverviewDuPont de Nemours, Inc. (DD) is a global provider of advanced materials and solutions, now classified as Industrials. It operates through Health Care & Water Te
DuPont de Nemours, Inc. (DD) is a global provider of advanced materials and solutions, now classified as Industrials. It operates through Health Care & Water Technologies (~47% of Q2 2026 sales) and Diversified Industrials (~53%). Health Care & Water offers medical packaging, biopharma, and water purification. Diversified Industrials serves aerospace, automotive (including EV battery adhesives), and construction, leveraging innovation and AI.
Search Keywords Brand Product
- Kapton polyimide films
- Kevlar micrometeoroid shielding
- Liveo portfolio
- Tyvek garments
- ion exchange resins
- water membranes
- EV battery adhesives
- direct lithium extraction solutions
- specialty chemicals
- advanced materials
- healthcare technologies
- water purification
- diversified industrials
- aerospace materials
- electric vehicle components
- biopharma market
- semiconductor materials
- operational excellence
- 80/20 strategy
- AI-ready labs
Search Keywords Event Phrases
- DuPont Q2 2026 earnings
- DuPont share repurchase
- DuPont reverse stock split
Search Keywords Policy Regulatory
- GICS code Industrials
- What They Do (Plain English & Analogies)
- DuPont is like a specialized ingredient supplier for many different industries. Instead of making finished products you buy in a store, they create the advanced materials and solutions that other companies use to make their products better, safer, or more efficient. Think of them as providing the 'super-ingredients' for things like medical devices, water filters, car parts, and electronic components. For example, they make special films that protect satellites from extreme temperatures, materials that purify drinking water, and strong, lightweight components for electric vehicles. They essentially help other businesses innovate and solve complex material challenges.
- Very Brief History
- DuPont was founded in 1802 by Éleuthère Irénée du Pont de Nemours as a gunpowder mill in Delaware. Over two centuries, it evolved into one of the world's largest diversified chemical companies, developing iconic products like nylon, Teflon, Mylar, Kapton, and Kevlar. In 2017, it merged with Dow Chemical Company to form DowDuPont, which then split into three independent companies in 2019: Corteva (agrisciences), Dow Chemical Company (materials sciences), and DuPont de Nemours, Inc. (specialty products). More recently, in April 2026, DuPont divested its Aramids business.
- "Street Stereotype"
- DuPont is generally perceived as a global specialty chemicals and advanced materials company with a long history of innovation, but also one that has undergone significant portfolio transformation and divestitures in recent years. Investors and analysts often view it as a company focused on high-margin, technology-driven solutions, particularly in healthcare and water technologies, while also navigating cyclicality in industrial markets. There's a focus on its ability to drive growth through innovation, disciplined capital allocation, and operational excellence, including the implementation of strategies like 80/20.
- Subsidiaries On Linked In*
- {"subsidiaries":[]}
- Customer Sectors & Example Clients
- DuPont's customers operate in a wide array of sectors including healthcare (medical packaging, biopharma, medical devices, personal protection), water (industrial water, semiconductor manufacturing, desalination), and diversified industrials (aerospace, automotive, electric vehicles, battery energy storage systems, building technologies, residential and nonresidential construction, printing applications, consumer goods). Likely clients, based on their business model and industries, would include: * **Healthcare:** Medical device manufacturers (e.g., Medtronic, Johnson & Johnson), pharmaceutical companies (e.g., Pfizer, Merck). * **Water:** Municipal water treatment facilities, semiconductor manufacturers (e.g., Intel, TSMC, Samsung). * **Diversified Industrials:** Major automotive OEMs (e.g., Ford, GM, Tesla, BMW), aircraft manufacturers (e.g., Boeing, Airbus), construction companies (e.g., Lennar, PulteGroup), electronics manufacturers.
- New Customers / Segments They'Re Targeting
- DuPont is targeting new opportunities in several areas. They launched an integrated end-to-end solution for direct lithium extraction (DLE), including membranes and ion exchange resins, designed to improve lithium recovery and purity. In Healthcare, they are expanding their Liveo portfolio to better serve the high-growth biopharma market. For Diversified Industrials, they are bringing forward new solutions for electric vehicles (EVs) and battery energy storage systems, particularly adhesives for EV batteries, where they are seeing nice growth in European markets. The company is also using its AI-ready labs initiative to accelerate development cycles and strengthen its innovation pipeline. Additionally, they are rapidly scaling sales plays using AI to accelerate impact in areas like the garment space, leading to incremental sales.
- Sales Geographies And Expansion Plans
- DuPont sells its products globally, serving markets across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. The company has observed strong order growth trends across most of its key end markets globally. While no explicit plans for expanding into entirely new geographical regions were disclosed, DuPont is focused on driving growth within its existing global footprint by leveraging innovation and commercial execution in attractive end markets. They are actively pursuing large projects in the Middle East for their Water business, which are expected to contribute significantly to revenue in the second half of 2026. The company also noted strong growth in the EV battery space, particularly in European markets.
- How Key Themes May Help/Hurt
- DuPont is positioned to both benefit from and be challenged by the 'Space Supply Chain '26: Aerospace Composites, Materials & Alloys' and 'AI Bottleneck '26: Upstream AI Materials' themes. **Space Supply Chain '26: Aerospace Composites, Materials & Alloys:** * **Help:** DuPont is a key supplier within this theme, known for its Kapton polyimide films for orbital thermal management and Kevlar for micrometeoroid shielding. The theme's bullish drivers, such as the accelerating commercial aerospace recovery, robust global defense spending, and expanding space exploration initiatives, directly benefit DuPont's Diversified Industrials segment, which is already experiencing strong growth in aerospace. Increased demand for lightweight, high-performance materials will drive sales of these specialized products. * **Hurt:** The theme's bear case highlights potential supply chain bottlenecks, production ramp-up challenges, and geopolitical instability (e.g., Middle East conflicts). These factors could impact raw material costs and logistics for DuPont, potentially pressuring margins or delaying project execution, despite the company's mitigation strategies. **AI Bottleneck '26: Upstream AI Materials:** * **Help:** DuPont is actively investing in AI-ready labs and digital/AI capabilities to enhance its development cycles and operational performance. More directly, the exponential growth of AI and data centers is fueling demand for critical materials in semiconductors. DuPont's Water business provides ultra-pure water to chip manufacturers, a segment that has seen 20%+ growth, directly benefiting from this trend. This theme creates high-growth end markets for advanced engineered materials that DuPont supplies. * **Hurt:** The bear case for this theme points to exposure to broader macroeconomic cyclicality and potential delays in plant capacity expansions. While DuPont is focused on growth, a broader economic slowdown could still impact demand in some industrial segments, and any delays in customer capacity expansion could affect DuPont's material sales.
3 Main Long-Term Bull Details
- Strategic Portfolio Transformation towards High-Growth Markets: DuPont is actively shifting its portfolio towards high-margin, technology-driven solutions, particularly in Healthcare & Water Technologies, with a goal to reach 2/3 of its portfolio in this space over the medium term. This focus on areas like biopharma, medical devices, and industrial water, driven by global megatrends such as an aging population and increased healthcare access, provides sustainable growth opportunities.
- Robust Innovation Engine and Operational Excellence: The company boasts a strong vitality index of about 35% and is committed to continuous innovation, leveraging AI-ready labs for faster product development and a more robust pipeline. Coupled with a disciplined business system focused on operational excellence (OpEx) and the 80/20 strategy, DuPont is driving significant productivity gains, margin expansion, and improved customer experience.
- Disciplined Capital Allocation and M&A Capacity: DuPont maintains a balanced approach to capital allocation, including a recently announced $250 million share repurchase and a prudent M&A strategy. With well over $1 billion in proceeds from past divestitures, the company has significant capacity to pursue accretive acquisitions, particularly in healthcare and water, to further enhance its growth profile and shareholder value.
3 Main Long-Term Bear Details
- Exposure to Macroeconomic and Geopolitical Headwinds: Despite strategic shifts, DuPont remains susceptible to global economic downturns and geopolitical instability. The Middle East conflict, for example, has caused logistics disruptions and impacted water business sales, requiring price increases to offset higher input costs. Continued or escalating global instability could negatively impact demand, supply chains, and profitability.
- Cyclicality in Diversified Industrial Markets: While some areas like aerospace and EV battery applications show strength, segments such as construction and certain printing applications can experience cyclical weakness. This uneven demand in diversified industrials can dampen overall revenue growth and margins, making the company vulnerable to market fluctuations.
- Operational Execution and Margin Pressures from Input Costs: While focused on operational excellence, the company faces challenges in managing increased input costs, particularly from oil and gas inflation, which can create margin pressures. Although pricing actions are in place to achieve dollar neutrality, sustained inflation or unforeseen operational disruptions could hinder the achievement of margin expansion targets.
- Competitors And Differentiation
- The earnings transcript does not explicitly name DuPont's competitors. However, DuPont differentiates itself through several key strategies: * **Advanced Materials Science and Application Expertise:** The company focuses on providing specialized, high-performance materials and integrated solutions tailored to customer needs, rather than commodity chemicals. * **Innovation Excellence:** DuPont maintains a strong vitality index (35%) and emphasizes a robust front-end innovation pipeline, faster development cycles, and the expansion of its AI-ready labs initiative. * **Commercial Excellence:** They are leveraging AI to accelerate sales impact and demand generation, which has led to a higher win rate (30% in garment sales plays compared to a typical high teens percentage). * **Operational Excellence (OpEx) and 80/20 Strategy:** DuPont is building a disciplined operating culture to improve productivity, quality, customer delivery, and costs. The 80/20 work aims to simplify complexity and concentrate resources on the highest-value opportunities. * **Strategic Portfolio Shift:** The company has a stated goal to strategically shift its portfolio more towards high-growth Healthcare & Water Technologies.
- Recent Performance & What The Market'S Focused On
- DuPont reported strong second-quarter 2026 financial results, which again exceeded its previously communicated guidance. The company delivered 4% organic sales growth, 80 basis points of margin expansion, double-digit adjusted EPS growth, and robust free cash flow conversion in the quarter. As a result of this outperformance, DuPont is again raising its full-year 2026 financial guidance for organic sales growth (now slightly ahead of 4%), operating EBITDA (midpoint increased to $1.760 billion), and adjusted EPS (midpoint increased to $7.24). The company expects its full-year free cash flow conversion to be ahead of its 90% target, closer to 100%. The market is currently focused on: * **Continued organic sales growth:** Particularly in the Healthcare & Water Technologies segment (expected mid-single-digit organic growth in Q3) and sustained strength in aerospace and electric vehicle battery applications within Diversified Industrials (expected low single-digit organic growth in Q3). * **Operating EBITDA margin expansion:** Despite a 30 basis point headwind from price/cost dynamics in Q2 and expected oil and gas inflation in the second half, the company is demonstrating strong margin momentum driven by productivity and leverage on growth. * **Progress on the business system and 80/20 initiatives:** Investors are watching for tangible benefits from these programs in terms of margin improvement, simplified operations, and increased focus on high-value opportunities. * **Capital allocation:** The announced $250 million share repurchase and the potential for accretive M&A in healthcare and water, leveraging remaining proceeds from divestitures, are key areas of interest. * **Resolution of Middle East conflict impacts:** The Water business experienced weakness in the Middle East due to project timing shifts, and the market is monitoring for a return to a more normal growth profile in the region.
- Revenue Segments And Estimated Mix
- Healthcare & Water Technologies — Mix: ~47.1%; Source: Q2 2026 transcript; Trend: Net sales of $856 million, up 5% YoY, on 4% organic growth. Organic growth was broad-based, led by double-digit gains in personal protection and biopharma markets. Water sales up low single-digits organic, with double-digit gains in industrial water and semiconductor markets, partially offset by weakness in the Middle East. Operating EBITDA margin of 30.1%. Expected mid-single digit organic sales growth in Q3.
- Diversified Industrials — Mix: ~52.9%; Source: Q2 2026 transcript; Trend: Net sales of $963 million, up 3% YoY, on 3% organic growth. Building Technologies up low single-digits organic (residential and nonresidential construction, led by Asia Pacific). Industrial Technologies up mid-single digits organic (aerospace, electric vehicle battery applications, printing applications). Operating EBITDA margin of 22.1%. Expected low single-digit organic sales growth in Q3.
- Product Brands
- FILMTEC
- Tyvek
- Liveo
- Amberlite
- Tychem
- INGE
- ITEGRATEC
- CORIAN
- Vespel
- MOLYKOTE
- BETAFORCE
- BETASEAL
- Kapton
- Tedlar
- MemCor
- OxyMem
- Artistri Digital Inks
- Cyrel Flexographic Solutions
- Kevlar
Bull / Bear DetailsDuPont de Nemours, Inc. (DD) is a compelling long opportunity, driven by its strategic transformation into an Industrials-classified company (effective July 202
Thesis
DuPont de Nemours, Inc. (DD) is a compelling long opportunity, driven by its strategic transformation into an Industrials-classified company (effective July 2026) and strong operational execution. Robust organic growth, significant margin expansion, and disciplined capital allocation, including share repurchases and targeted M&A in high-growth Healthcare & Water and EV markets, underpin its value creation. This thesis was updated on 2026-08-31.
Bull case
DuPont's strong innovation engine, evidenced by a 35% vitality index and AI-ready labs, drives new solutions in high-growth areas like direct lithium extraction, biopharma, and electric vehicle battery systems. The company's GICS reclassification to Industrials in July 2026 validates its strategic portfolio transformation, focusing on differentiated, high-value materials.
The company consistently exceeds guidance, delivering 4% organic sales growth and 80 basis points of margin expansion in Q2 2026. Initiatives like the 80/20 process, operational excellence, and a target of 3% net productivity (COGS annual reduction) within 18 months are driving measurable improvements in productivity, quality, and costs, leading to robust free cash flow conversion.
DuPont maintains a balanced and disciplined capital allocation strategy, evidenced by the announced $250 million share repurchase for Q3 2026. With over $1 billion in dry powder, the company is actively pursuing accretive M&A opportunities in the high-growth Healthcare and Water sectors, aiming to further shift its portfolio towards these strategic areas.
Bear case
Despite mitigation efforts, DuPont remains susceptible to geopolitical instability, as seen with the Middle East conflict impacting water business sales and project timing. Currency headwinds from a strengthening U.S. dollar also negatively impact net sales guidance, reflecting ongoing exposure to dynamic global economic conditions.
While overall margins expand, the Healthcare & Water Technologies segment experienced a 30 basis point margin contraction in Q2 2026 due to less favorable mix and growth investments. Additionally, full-year operating EBITDA margins are expected to face a 30 basis point headwind from oil and gas inflation, indicating persistent cost pressures.
Although some diversified industrial markets show strength (aerospace, EV), certain areas like single-family residential construction remain soft. The water business's full-year organic growth guidance was slightly tempered to low to mid-single digits due to Middle East weakness, highlighting continued cyclicality and regional sensitivities in parts of the portfolio.
Bull / Bear Case
- Bear Case
- DuPont remains exposed to macroeconomic and geopolitical headwinds, with the Middle East conflict tempering full-year water business growth guidance to low to mid-single digits and a strengthening U.S. dollar creating currency headwinds. Despite overall margin expansion, the Healthcare & Water Technologies segment experienced a 30 basis point margin contraction in Q2 2026 due to mix and growth investments. Furthermore, full-year operating EBITDA margins are expected to face a 30 basis point headwind from oil and gas inflation, indicating persistent cost pressures. Cyclicality in diversified industrial markets, particularly soft single-family residential construction, and execution risks associated with ambitious productivity targets and sales force compensation changes, also present challenges.
- Bull Case
- DuPont is undergoing a strategic transformation, evidenced by its GICS reclassification to Industrials and a focused shift towards high-growth Healthcare & Water Technologies, aiming for two-thirds of its portfolio in this segment. The company consistently exceeds financial guidance, delivering 4% organic sales growth and 80 basis points of margin expansion in Q2 2026, driven by robust operational excellence, 80/20 initiatives, and a target of 3% net productivity. Innovation, with a 35% vitality index and AI-ready labs, is fueling new solutions in direct lithium extraction, biopharma, and the rapidly growing EV battery market. Disciplined capital allocation, including a $250 million share repurchase and over $1 billion for accretive M&A in strategic areas, further underpins value creation.
- More Compelling & Why
- Bear. Given a hypothetical EV/EBITDA of 15x compared to an industry average of 12x, DuPont's valuation appears stretched. While operational execution is strong, the premium valuation does not adequately account for persistent margin pressures from inflation and geopolitical risks impacting the Water business. A sustained acceleration in organic growth, consistently exceeding mid-single-digit expectations, coupled with operating EBITDA margin expansion above 25%, would flip my view.
Key Factors
| Key Factor | Why It Matters | What To Watch | What It Signals | Where/How To Track | Free Alt Data | Paid Alt Data |
|---|---|---|---|---|---|---|
| Water Business Performance and Middle East Project Realization | Geopolitical stability and successful project execution in the Middle East are crucial for the Water segment's performance, a strategic growth area. Delays or further disruptions could impact revenue and overall segment growth targets, affecting the company's long-term portfolio shift. | Confirmation of large water project revenue hitting in Q4 2026. Full-year 2026 Water segment organic sales growth within the revised low-to-mid single-digit range. | Bullish if Q4 2026 sees expected revenue from Middle East projects materialize and full-year Water organic growth is at the mid-single-digit or higher end of the revised range. Bearish if Q4 projects are further delayed or full-year Water organic growth falls below the low end of the revised guidance. | DuPont's Q3 and Q4 2026 earnings calls and associated press releases, 10-Q/K filings. | News reports on Middle East geopolitical developments, industry publications covering large-scale water infrastructure projects in the region. | Supply chain risk monitoring platforms, geopolitical intelligence services. |
| Realization of EBITDA Benefits from 80/20 Process | The 80/20 strategy is critical for simplifying complexity, focusing resources on high-value opportunities, and driving sustained margin expansion across the organization. Tangible EBITDA benefits confirm effective operational restructuring, enhancing overall profitability and resource allocation efficiency. | Specific quantification of 'a few million dollars' in EBITDA benefit from 80/20 in H2 2026. Updates on the broader rollout of the 80/20 process beyond the initial 4 Diversified Industrials businesses. | Bullish if the company reports tangible EBITDA benefits from 80/20 in H2 2026 that meet or exceed 'a few million dollars' and announces plans for broader implementation. Bearish if benefits are less than expected or implementation faces delays. | DuPont's Q3 and Q4 2026 earnings calls and associated press releases. | Business news articles on corporate restructuring or efficiency initiatives. | Management consulting reports on operational efficiency programs. |
| Organic Sales Growth in Key Strategic Segments | Strong organic sales growth in Healthcare, Industrial Water, Aerospace, and EV Battery segments validates DuPont's portfolio transformation. It demonstrates the company's ability to capitalize on secular trends, driving top-line expansion and market share gains in high-growth areas. | Q3 2026 organic sales growth for Healthcare & Water Technologies (mid-single digits) and Diversified Industrials (low single digits, specifically aerospace and EV battery applications). Progress of EV battery revenue towards triple digits in 2026/2027. | Bullish if Q3 organic growth for Healthcare & Water Technologies exceeds mid-single digits and Diversified Industrials exceeds low single digits, especially driven by aerospace and EV battery applications. Bullish if EV battery revenue trajectory indicates exceeding triple digits in 2026. Bearish if segment organic growth falls below guidance. | DuPont's Q3 and Q4 2026 earnings calls and associated press releases, 10-Q/K filings. | Industry reports on healthcare, water treatment, aerospace, and EV market growth. News on major EV OEM production volumes. | EV production data from automotive intelligence firms, aerospace build rate trackers, healthcare market intelligence reports. |
| Operating EBITDA Margin Performance and Net Productivity Progress | Operating EBITDA margin expansion is a key indicator of DuPont's operational efficiency, cost management, and the success of its productivity initiatives. Consistent margin improvement directly impacts profitability and shareholder value, validating strategic execution and cost control efforts. | Q3 2026 operating EBITDA margin (guidance: 24.4%). Full-year 2026 operating EBITDA margin (guidance: 24.5%). Progress towards the 3% net productivity (COGS annual reduction) target. | Bullish if Q3 operating EBITDA margin exceeds 24.4% or if full-year operating EBITDA margin guidance is raised above 24.5%. Bullish if net productivity shows strong progress towards the 3% target within 18 months. Bearish if Q3 margin falls below expectations or full-year guidance is lowered. | DuPont's Q3 and Q4 2026 earnings calls and associated press releases, 10-Q/K filings. | Industry reports on raw material costs (e.g., oil, natural gas prices), manufacturing productivity benchmarks. | Commodity price data from financial terminals, supply chain cost analytics platforms. |
| Execution of Share Repurchase and Strategic M&A Announcements | Disciplined capital allocation, including share repurchases and strategic, accretive M&A, is crucial for enhancing shareholder value. It accelerates DuPont's portfolio shift towards higher-growth segments, optimizing capital structure and driving long-term growth through targeted acquisitions. | Completion of the $250 million share repurchase in Q3 2026. Announcements of new M&A deals, particularly in Healthcare or Water, that meet the stated criteria (mid-teen gross valuation, lower teens net post-synergies, incremental to growth). | Bullish if the $250 million share repurchase is completed as planned in Q3. Bullish if an M&A announcement is made for an asset in Healthcare or Water that is accretive to growth and meets the valuation targets. Bearish if the share repurchase is delayed or if M&A activity is delayed or non-accretive. | Company press releases, SEC filings (8-K for M&A, 10-Q for share repurchase updates), future earnings calls. | Financial news outlets covering M&A rumors or announcements, company investor relations website for capital allocation updates. | M&A databases (e.g., S&P Capital IQ, Refinitiv Eikon) for deal flow and valuation analysis, M&A advisory firm reports. |
Key Reported Metrics, Reratings Triggers & ResultsThis segment is a strategic growth driver for DuPont, with a stated goal to shift the portfolio towards this area. Its organic sales growth highlights success i
Upcoming print · 2026-11-05
| Key reported metrics | ||
|---|---|---|
| Metric | Last period | Why it matters |
| Healthcare & Water Technologies Organic Sales Growth | Net sales of $1.8 billion (4% organic sales growth) in Q2. Full-year 2026 organic sales growth guidance: slightly ahead of 4%. | This segment is a strategic growth driver for DuPont, with a stated goal to shift the portfolio towards this area. Its organic sales growth highlights success in key end markets like medical packaging, biopharma, and industrial water. |
| Operating EBITDA Margin | Second quarter operating EBITDA of $448 million (8% y/y growth); Operating EBITDA margin of 24.6% (+80 bps y/y) in Q2. Full-year 2026 Operating EBITDA guidance raised to $1.760 billion (midpoint); Full-year Operating EBITDA margin guidance of 24.5%. | Operating EBITDA margin is a crucial profitability metric, reflecting operational efficiency and margin expansion. Investors will watch Q3 performance against guidance, especially considering oil and gas inflation headwinds and productivity gains from initiatives like 80/20. |
| Organic Sales Growth | Net sales of $1.8 billion (4% organic sales growth) in Q2. Full-year 2026 organic sales growth guidance: slightly ahead of 4%. | This metric indicates the underlying health and demand for DuPont's products, excluding currency impacts and acquisitions/divestitures. It's a key indicator of top-line performance and market penetration, and management provided specific guidance for Q3 2026. |
Last reported · 2026-08-04
| Key reported metrics | Rerating thresholds | Earnings results | ||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Last period | Why it matters | What's needed for rerating | Rerating context | Earnings date | Actual reported | Hit target? | Notes |
| Health Care & Water Technologies Organic Sales Growth | 3% | This segment is a strategic growth driver for DuPont, with a stated goal to shift the portfolio towards this area. Its organic sales growth highlights success in key end markets like medical packaging, biopharma, and industrial water. | For DuPont de Nemours, Inc. (DD) to rerate higher, the Health Care & Water Technologies Organic Sales Growth metric needs to hit at least high single-digits (7-9%) for Q2 2026. This would significantly exceed the Q1 2026 value of 3% and the company's Q2 guidance of approximately mid-single-digit growth for the segment, aligning with a recent analyst estimate of 7% organic growth for this segment. | Achieving high single-digit growth validates DuPont's strategic pivot to high-growth Health Care & Water Technologies. It signals successful execution in key markets, demonstrating accelerated growth prospects and a favorable business mix, crucial for a positive rerating and confirming the long-term investment thesis. | Net sales of $856 million (4% organic growth) in Q2. | No | The Healthcare & Water Technologies segment reported 4% organic sales growth in Q2 2026. This was below the rerating trigger of at least high single-digits (7-9%). Management attributed the lower margin in this segment to a less favorable mix (less healthcare sales in Q2 compared to Q1) and growth investments, while underlying margins remained strong. They also noted that Water sales were partially offset by weakness in the Middle East, though outside of the Middle East, organic sales increased mid-single-digit percent. | |
| Operating EBITDA | 15% | Operating EBITDA is a crucial profitability metric for DuPont, reflecting the company's operational efficiency and ability to expand margins. Strong EBITDA growth signals effective cost management and favorable mix. | For DuPont de Nemours, Inc. (DD) to rerate higher, the Operating EBITDA margin needs to hit 25% or higher in Q2 2026, significantly exceeding the company's Q2 2026 implied guidance of approximately 23.9% and improving on the Q1 2026 reported margin of 24.6%. Additionally, a higher rerating would require a corresponding increase in the full-year 2026 Operating EBITDA guidance beyond the current $1.730-$1.760 billion, implying a full-year margin of at least 24.5%. | Achieving a 25%+ Operating EBITDA margin and raising full-year guidance signals superior operational execution and cost management. This validates DuPont's strategic pivot and productivity, reinforcing margin durability and disciplined capital allocation, leading to a higher valuation multiple as investor confidence grows. | Second quarter operating EBITDA of $448 million (8% y/y growth); Operating EBITDA margin of 24.6% (+80 bps y/y) in Q2. Full-year 2026 Operating EBITDA guidance raised to $1.760 billion (midpoint); Full-year Operating EBITDA margin guidance of 24.5%. | Partially | Management reported Q2 operating EBITDA of $448 million, an 8% increase year-over-year, with an operating EBITDA margin of 24.6%. This Q2 margin did not hit the 25% rerating trigger and was not an improvement on the prior quarter's 24.6%. However, the company raised its full-year 2026 operating EBITDA guidance to a midpoint of $1.760 billion, which is the high end of the previous guidance range, and maintained a full-year operating EBITDA margin guidance of 24.5%, meeting that specific part of the rerating trigger. | |
| Organic Sales Growth | 2% | This metric indicates the underlying health and demand for DuPont's products, excluding currency impacts and acquisitions/divestitures. It's a key indicator of top-line performance and market penetration. | For DuPont de Nemours, Inc. (DD) to rerate higher, the company needs to report Q2 2026 organic sales growth of at least 4%, exceeding its current guidance of approximately 3%. Additionally, it must raise its full-year 2026 organic sales growth outlook to 5% or more, surpassing its current guidance of approximately 4%. | Achieving Q2 organic sales growth of 4%+ and raising full-year guidance to 5%+ would signal a significant acceleration beyond current expectations. This validates DuPont's strategic shift towards high-growth segments like Health Care & Water, demonstrating effective operational execution and a stronger competitive position, driving a positive rerating. | Net sales of $1.8 billion (4% organic sales growth) in Q2. Full-year 2026 organic sales growth guidance: slightly ahead of 4%. | Partially | The company reported Q2 organic sales growth of 4%, meeting the rerating trigger for the quarter. However, the full-year 2026 organic sales growth guidance was raised to 'slightly ahead of 4%', which did not meet the rerating trigger's requirement of 5% or more. Management highlighted that this was driven by outperformance in the quarter and continued strength across most key end markets. | |
Key QuestionsWill DuPont's Water business achieve its projected high single-digit organic growth in the second half of 2026, particularly with the anticipated realization of
Will DuPont's Water business achieve its projected high single-digit organic growth in the second half of 2026, particularly with the anticipated realization of Middle East projects in Q4, or will geopolitical disruptions continue to temper performance?
- Question 2
Can DuPont sustain its operating EBITDA margin expansion in Q3 2026, particularly given the anticipated 50 basis point headwind from oil and gas inflation, and will the 'few million dollars' of EBITDA benefits from the 80/20 process materialize as expected in the second half?
- Question 3
Will the accelerated organic sales growth in the second half of 2026, driven by continued strength in Healthcare, aerospace, and the rapidly growing EV battery applications, validate DuPont's strategic portfolio shift, and will the announced $250 million share repurchase be completed as planned in Q3?
Earnings Transcript Summary
· 2026Q2 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 3 Things Management Is Most Focused On1. Driving operational excellence and productivity: Management emphasized exceeding guidance through ongoing focus on excellence and productivity, delivering organic sales growth, margin expansion, and robust free cash flow conversion. This is supported by a disciplined business system focused on organic growth, accountability, execution, and continuous improvement, including innovation, commercial, and operational excellence, and 80/20 initiatives. 2. Disciplined capital allocation: DuPont announced a $250 million share repurchase in the third quarter, highlighting a continued focus on a disciplined capital allocation model. The company also noted having over $1 billion for potential M&A, particularly in Water and Healthcare. 3. Strategic portfolio transformation and market alignment: The company completed a reverse stock split to align with industrial peers and achieved a GICS code classification change to Industrials, reflecting its significant transformation and industrial portfolio. They are also focused on advancing strategic priorities through innovation in high-growth applications like direct lithium extraction, biopharma, and electric vehicles. | Call Takeaway & ToneThe overall takeaway of the call was positive, with DuPont reporting second-quarter financial results that exceeded previously communicated guidance and subsequently raising its full-year 2026 financial outlook for organic sales growth, operating EBITDA, and adjusted EPS. The tone was confident and optimistic, highlighting strong execution, robust free cash flow conversion, and progress on strategic priorities such as disciplined capital allocation (including a new share repurchase), portfolio transformation (GICS reclassification to Industrials), and the implementation of a disciplined business system focused on innovation, commercial, and operational excellence. Management effectively addressed analyst concerns regarding segment performance, operational improvements, and geopolitical impacts, reinforcing confidence in the company's trajectory. | Prior Quarter'S Y/Y Growth By SegmentHealthcare & Water Technologies (Q1 2026): 3% organic sales growth year-over-year; Diversified Industrials (Q1 2026): about flat organic sales growth year-over-year. | 3 Things Analysts Most Pressed On (And Mgmt Responses)1. Innovation contribution, product vitality, and operational metrics (cost of poor quality, OTIF): Analysts inquired about the tangible impact of innovation and the progress on operational improvements. Management responded that the vitality index is about 35%, with a focus on shifting the mix towards growth, improving the front-end pipeline, and reducing cycle speed. They noted cost of poor quality is below benchmark at about 4% of sales, with further reduction expected. 2. Net productivity goals and compensation plan changes: Analysts asked about the company's net productivity targets and how compensation plans are being adjusted to drive cultural change. Management stated a target of 3% net productivity (COGS annual reduction), with about 200 basis points achieved in the quarter, expecting to reach the 3% run rate within 18 months. They also mentioned changing short-term incentive compensation to the line of business level for 2026 and moving the sales force to a commission-based structure in 2027 to incentivize growth. 3. Middle East Water business headwinds and Healthcare & Water Technologies segment margins: Analysts sought an update on the Middle East conflict's impact on water projects and the reasons for margin contraction in the Healthcare & Water Technologies segment. Management clarified that the $10 million shift from Q1 to Q2 occurred, and they still expect improved performance in the Middle East in the second half, primarily in Q4, driven by existing projects. They emphasized no structural change, with the rest of the Water business performing well (mid-single-digit organic growth ex-Middle East). The margin contraction in Healthcare & Water was attributed to a mix shift (less healthcare sales in Q2 compared to Q1) and growth investments, while underlying margins remain strong. | Revenue SegmentsHealthcare & Water Technologies: 4% organic sales growth year-over-year; Diversified Industrials: 3% organic sales growth year-over-year. |
· 2026Q1 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 3 Things Management Is Most Focused On1. Driving growth and continuous improvement: Management is focused on strengthening its performance-based culture, emphasizing innovation, commercial execution, and operational excellence, supported by the implementation of its business system and digital/AI capabilities. 2. Disciplined capital allocation: DuPont is committed to returning cash to shareholders, as evidenced by the announced $275 million accelerated share repurchase, and is prudently evaluating M&A opportunities for accretive growth, leveraging proceeds from the Aramids divestiture. 3. Sustainability: The company recently issued its 2026 sustainability report and announced new 2035 sustainability goals, focusing on sustainable innovation, resilient operations, and people, partners, and communities to drive growth and operational excellence. | Call Takeaway & ToneThe overall takeaway of the call was positive, highlighting DuPont's strong operational start to 2026, with results exceeding guidance and a subsequent raise in full-year financial outlook. The tone was confident and optimistic, emphasizing disciplined execution, robust margin expansion driven by both favorable mix and productivity, and solid free cash flow generation despite external macro and geopolitical headwinds. Management expressed confidence in their strategic priorities, including capital allocation, sustainability, and continuous improvement initiatives like the 80/20 process, while actively managing challenges such as Middle East logistics disruptions and raw material inflation through proactive pricing actions. | Prior Quarter'S Y/Y Growth By SegmentHealthcare & Water Technologies (Q4 2025): 3% organic sales growth y/y; Diversified Industrials (Q4 2025): 4% organic sales decline y/y. | 3 Things Analysts Most Pressed On (And Mgmt Responses)1. **Impact of Middle East conflict on the water business and mitigation strategies:** Analysts inquired about the financial impact and customer base disruptions. Management responded that approximately $10 million in water sales were impacted in Q1 but have since shipped in April, and teams have found alternative routes to mitigate disruptions, with minimal impact baked into Q2 guidance. They expect full-year water growth to be mid-single digits, with a stronger second half due to project timing. 2. **Drivers of strong margin expansion and sustainability:** Analysts questioned whether margin expansion was primarily due to mix or operational improvements. Management clarified that both mix (50 basis points) and net productivity (70 basis points) contributed significantly to Q1 margins, indicating strong underlying performance and progress towards their 3-year targets. 3. **Pricing strategy and ability to offset rising input costs:** Analysts asked about the company's ability to push through price increases given rising raw material and logistics costs. Management stated that surcharges and price increases are already in place (starting April 1 or May 1) to cover an expected $90 million in incremental costs, with the organization demonstrating a strong ability to pivot and customers generally being constructive in discussions as the company aims to cover costs, not profit. | Revenue SegmentsHealthcare & Water Technologies: 3% organic sales growth y/y; Diversified Industrials: about flat organic sales growth y/y. |
Transcript Tidbits
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| About Expanding Eligible MarketDuPont launched an integrated end-to-end solution for direct lithium extraction (DLE), including membranes and ion exchange resins, to improve lithium recovery and purity. The DLE market is estimated to be around $200 million, and DuPont is well-positioned to capitalize on its growth. In Healthcare, the company continued to expand its Liveo portfolio to better serve the high-growth biopharma market. For Diversified Industrials, new solutions are being introduced for electric vehicles (EVs) and battery energy storage systems. The EV battery space currently generates about $70 million in revenue and is projected to reach triple digits in 2026 and 2027, with the broader EV opportunity for DuPont being a few hundred million dollars. The company has also invested in additional sales resources within its Tyvek business to fill assets, leading to incremental garment sales. DuPont aims to strategically shift its portfolio over the medium term to have two-thirds in the Health Care & Water space, targeting growth above market. | About CompetitionThe transcript does not contain explicit discussions about competition. | About The Broader IndustryTop-line growth was broad-based, driven by continued strength in healthcare, aerospace, industrial water, and semiconductor markets. The Building Technologies business saw year-over-year growth in both residential and nonresidential end markets, particularly in Asia Pacific. Healthcare sales experienced mid-single-digit organic growth, with double-digit gains in personal protection and biopharma markets. Water sales showed low single-digit organic growth, boosted by double-digit gains in industrial water and semiconductor markets, though partially offset by weakness in the Middle East. Industrial Technologies recorded mid-single-digit organic sales growth, with double-digit gains in aerospace and electric vehicle battery applications, alongside mid-single-digit growth in printing applications. The AI revolution is driving demand for ultra-pure water in chip manufacturing, where DuPont participates, with this segment growing in the 20%-plus range. Non-residential construction growth is primarily in the healthcare, education, and retail (HHEP) markets, rather than data centers. In residential construction, the multifamily space is showing nice growth, while single-family homes remain soft. | Where Things Are HeadedDuPont is raising its full-year 2026 financial guidance for organic sales growth, operating EBITDA, and adjusted EPS, expecting free cash flow conversion to exceed its 90% target. A $250 million share repurchase is expected to launch in the third quarter. The company's GICS code classification changed to Industrials in July 2026, reflecting its transformation. The goal for the innovation pipeline is to maintain a 35% vitality index while shifting the mix more towards growth. DuPont targets a 3% net productivity (COGS annual reduction) within the next 18 months. In 2027, the compensation method for the sales force will shift to a commission-based structure to drive growth. The Water business is expected to achieve high single-digit growth in the second half of 2026, leading to low to mid-single-digit growth for the full year, despite Middle East-related revisions. DuPont maintains a robust M&A pipeline with over $1 billion for potential acquisitions, particularly in Healthcare (packaging and CDMO), targeting mid-teen gross valuations and lower teens net post-synergies, with acquired assets expected to be incremental to the overall growth algorithm. Full-year 2026 net sales guidance is slightly ahead of 4% organic growth, with operating EBITDA increased to $1.760 billion and adjusted EPS at $7.24, an 18% increase year-over-year. Second-half net sales are estimated at $3.675 billion, assuming about 6% organic growth. Third-quarter 2026 estimates include net sales of $1.835 billion, operating EBITDA of $448 million, and operating EBITDA margins of 24.4%. R&D expense is targeted at about 2.5% of sales, with a focus on differential management to drive outsized growth. | Updates On ThemeAerospace | Broader Themes EmergingUpstream AI Materials: DuPont is expanding its AI-ready labs initiative to accelerate development cycles and enhance its front-end pipeline. The company is rapidly scaling sales plays using AI to accelerate impact and is identifying significant improvement potential through early pilots of AI and automation in reliability, maintenance, and quality. The 'AI-driven demand for atoms' narrative is a significant second-order trend, with the exponential growth of AI and data centers fueling demand for critical materials in semiconductors and electrical infrastructure. The AI revolution is driving demand for ultra-pure water in chip manufacturing, where DuPont participates. | Bullish-Leaning Quotes (Short)“our second quarter financial results, which again exceeded our previously communicated guidance.” “We delivered organic sales growth of 4%, 80 basis points of margin expansion, double-digit adjusted EPS growth and robust free cash flow conversion in the quarter.” “we are again raising our full year 2026 financial guidance for organic sales growth, operating EBITDA and adjusted EPS.” “effective in July, our GICS code classification has been changed to Industrials, an important milestone that recognizes the significant transformation of DuPont over the past several years.” “We have won about 150 opportunities, which represents a nearly 30% win rate. This sits firmly ahead of our historical percentage as well as above industry benchmarks.” “Strong execution and market-driven growth in the second quarter delivered results ahead of our financial guidance.” “We delivered transaction-adjusted free cash flow of $326 million and related conversion of 127%.” “Adjusted EPS for the quarter of $1.88 was up 21% versus the year ago period.” “I'm optimistic we're doing a lot of work, but we'll be prudent with respect to the returns that we expect on a deal.” “The Water business continues to perform very well outside the Middle East conflict.” “In DI, we have a very strong order book on the industrial side within DI.” “Optimistic on the EV battery space.” | Bearish-Leaning Quotes (Short)“Operating EBITDA margin of 30.1% decreased 30 basis points year-over-year as organic growth and productivity were more than offset by less favorable mix and growth investments.” “Water sales were up low single-digits percent on an organic basis... partially offset by weakness in the Middle East.” “We have adjusted our midpoint to $7.175 billion due to a lower expected currency benefit as the U.S. dollar continues to strengthen.” “Operating EBITDA margins of 24.5% includes a 30 basis point headwind from oil and gas inflation.” “Currency is expected to be about a 1% headwind in the quarter.” “Our expectations now for the full year [Water] are more in the low to mid-single-digit range, really with the slight revision being driven just by what's going on in the Middle East.” “single-family homes continues to be, I would say, very soft in the space.” | HiringDuPont has invested in additional sales resources within its Tyvek business. For 2027, the company is changing the compensation method for its sales force, moving them to a commission-based structure. |
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) |
|---|---|---|---|---|---|---|---|
| About Expanding Eligible MarketDuPont intends to continue adding to its health care portfolio, with a robust pipeline of affordable and growth-accretive assets, focusing on broadening its net packaging offering and rounding out sales in the CDMO space. The company aims to shift its portfolio over the medium term to be 2/3 in the Health Care & Water space, moving more towards growth above market. | About CompetitionThe transcript does not contain explicit discussions about competition. | About The Broader IndustryThe company is navigating potential macro and geopolitical headwinds. There is continued softness in construction markets, particularly North America residential, while commercial and do-it-yourself segments are flattish, excluding data center volume. The overall construction market is expected to be flat for the full year 2026. Strength is noted in health care and aerospace markets. Automotive, specifically battery adhesive volumes for EVs, is showing strong growth, well above the 20% EV growth expectations, due to new volume and wins. The microelectronics market, particularly within ion exchange, is seeing nice volume driven by the broader data center trend. Demand in biopharma is recovering nicely. The printing and packaging businesses are expected to normalize and be up low single digits on a full-year basis. Key global megatrends driving health care demand include the aging population and increased access to health care, particularly for higher-end Class 3 medical devices and cardiovascular applications. | Where Things Are HeadedDuPont is raising its full-year 2026 financial guidance following a strong first quarter performance and price increases due to the Middle East conflict. The company expects to launch a $275 million accelerated share repurchase under its existing program. New 2035 sustainability goals have been announced, focusing on sustainable innovation, resilient operations, and people, partners, and communities, designed to drive growth and operational excellence. The implementation of the 80/20 process in Diversified Industrials is expected to lead to nice margin appreciation with minimal top-line impact over time. Approximately $10 million of stranded costs are expected to be removed in 2026, with the full $30 million targeted within the first two years. The water business is projected to be up mid-single digits for the full year, with a flat first half and high single-digit growth in the second half driven by large project timing. The company's full-year guidance anticipates the current Middle East conflict situation, including oil and natural gas prices, to continue through the remainder of the year, with pricing actions already in place to cover incremental costs. Health care sales are expected to be up mid-single digits to high single digits for the full year. DuPont aims to shift its portfolio over the medium term to be 2/3 in the Health Care & Water space. | Updates On ThemeAerospace | Broader Themes EmergingAI Materials: DuPont is investing in digital and AI capabilities, including a collaboration with an AI-driven platform for end-to-end product and application development to accelerate development and improve cycle times. They are expanding the use of data-enabled tools with AI capabilities to improve maintenance, accelerate defect detection, and optimize asset performance, converting operational data into actionable insights faster. Sustainability: The company issued its 2026 sustainability report and announced new 2035 sustainability goals focused on creating sustainably advanced solutions, reducing environmental footprint, and increasing renewable energy use. Operational Excellence: DuPont is strengthening its performance-based culture with an emphasis on growth and continuous improvement, implementing a business system, and focusing on fundamentals like safety, quality, delivery, inventory, and productivity through initiatives like Kaizen events. | Bullish-Leaning Quotes (Short)“our first quarter financial results, which exceeded our previously communicated guidance.” “We delivered organic sales growth of 2%, 130 basis points of pro forma margin expansion and double-digit adjusted EPS growth.” “We are well on our way to our 3-year targets that we laid out at our Investor Day.” “Our order trends in April were actually -- we have very similar demand as we have been seeing and nice increases overall on a year-over-year basis.” “We continue to be positioned nicely and realize the pipeline has been building over the last couple of years, frankly, as we got qualifications with the large OEMs.” “free cash flow generation is still expected to be greater than 90% for the year.” “We saw nice volume in the first quarter, as you would expect, just around the broader data center trend.” | Bearish-Leaning Quotes (Short)“While we are mindful of potential macro and geopolitical headwinds” “continued softness in construction markets and logistics disruptions due to the conflict in the Middle East.” “Our second quarter net sales guidance assumes about 3% organic growth year-over-year. Currency is expected to be a slight tailwind in the quarter.” “overall full year guidance anticipates that the current situation continues through the remainder of the year. So current oil prices, current natural gas prices, our assumption is that continues all year long.” “if this were to escalate or get even worse from where we are today, that would obviously have some impact on the assumptions that we've made” |
Notes
| Date | Comment | Comment Type | Comment Sentiment | Link | Price Reaction |
|---|---|---|---|---|---|
| 2026-08-04 | DuPont (DD) exceeded Q2 2026 guidance, raising its full-year outlook on strong organic growth in Healthcare & Water and Diversified Industrials, margin expansion, and a share repurchase. Despite some Middle East headwinds, the confident messaging and strategic transformation were well-received. The stock's 1.96% gain (outperforming SPY) post-earnings reflects positive market sentiment. | Earnings Transcript | Neutral | +1.96% (vs SPY: +0.52%) |
Upcoming Events
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type |
|---|---|---|---|---|---|---|---|---|
| DD_eae80ed0 | in the third quarter | 2026-07-01 | 2026-09-30 | Launch of a $250 million share repurchase program. | This demonstrates DuPont's disciplined capital allocation strategy and commitment to returning value to shareholders, which can be accretive to earnings per share and support stock price. | Ticker | 2026-08-04 | earnings_transcript |